BASF Venture Capital GmbH

Advanced BioNutrition Corp

Advanced BioNutrition Corp. (ABN), based in Columbia, USA, was founded by David Kyle in 2001 to introduce omega fatty acid biomass into the aquaculture market.

Using algae culture, ABN produces unsaturated fatty acids for use as a foodstuff for aquatic animals reared for human consumption (salmon, shrimps, tilapia, etc.). The fatty acids docosahexaenoic acid (DHA) and arachidonic acid (ARA), essential for the growth and development of fish, can be produced from renewable resources. Previously, DHA and ARA could only be provided in fish food by using fishmeal and fish oil that were not sustainably replaceable.

This idea, developed by ABN to solve crucial problems in aquaculture, could also have a potential impact in the area of “Functional Foods” in human nutrition in the future.

BASF Venture Capital has been investing in Advanced BioNutrition Corp., together with Arancia Industrial, Sherbrooke Capital and Emerald Technology Ventures, since December 2004.

Key Facts



Investment Year


Columbia, USA




Microencapsulation solutions to stabilize, protect, and deliver bioactives.



Dr. Michael Nettersheim
Investment Manager
Benckiserplatz 1, 67059 Ludwigshafen am Rhein

Complementary Links